September 7, 2022 Clinical Research The observational study claims for ivermectin’s efficacy continue but the evidence from RCTs continues to show that it is not a treatment for COVID.
August 30, 2022 Cardiovascular Diesase Unpublished observational study presented at the European Society of Cardiology conference reports that poor sleep could lead to increased cardiovascular disease risk.
August 29, 2022 Cardiovascular Diesase Study shows that post MI use of polypill combination of ASA, ACE-inhibitor, and statin as opposed to individual pill forms improved secondary prevention outcomes due to better adherence to treatment.
August 19, 2022 Allergy/Immunology Discovery of largely unchanged ‘weak spot’ in COVID-19 variants could lead to better treatment options
August 10, 2022 Allergy/Immunology A vaccine for Lyme disease is in its Phase 3 trial. Results to date show efficacy and safety. If trial is successful, official authorization expected in 2025.
August 9, 2022 Allergy/Immunology Scientists from Johns Hopkins University have genetically engineered an experimental nanobody that targets alpha-synuclein protein clumps thought to be involved in the pathophysiology of Parkinson’s disease
August 4, 2022 Bioengineering Study succeeds at restoring selected molecular and cellular processes across multiple vital organs after death in pigs. Far from human use and a plethora of bioethical questions remain to be addressed.
July 5, 2022 Clinical Research Amid buzz around the medical benefits of psilocybin, a new production facility gets to work in B.C. Studies are ongoing with early evidence pointing to its ability to relieve symptoms in adults suffering from treatment-resistant depression.
June 24, 2022 Clinical Research End of week wrap up: Not being able to stand on one legs means you die earlier?, Alzheimer an autoimmune disease?, and COVID vaccines saved millions of lives according to Lancet-published study.
